← Leaderboards
Osmond J D'cruz
Parker Hughes Institute
$2,530,319
Attributed
$2,530,319
Total exposure
10
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $478.7K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$2,530,319 · 10
By mechanism
R44$1,331,592 · 2
R43$700,001 · 7
R01$498,726 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationAntiaids AgentSpermicideDrug Design /Synthesis /ProductionPharmacokineticsLaboratory RabbitVaginaDrug Adverse EffectSexually Transmitted DiseasesScid MouseCatsVanadiumZidovudineAntiviral AgentsHuman Immunodeficiency Virus 1Feline Immunodeficiency VirusLaboratory MouseEmulsionsContraceptivesAids Education /PreventionRectum /AnusSemenFertilityFemale
Grant awards (13)
VANADOCENES AS A NEW CLASS OF SPERMICIDAL DRUGS$287,714
R44 · FY2007 · HD · contact PI
VANADOCENES AS A NEW CLASS OF SPERMICIDAL DRUGS$293,876
R44 · FY2006 · HD · contact PI
Phase II SBIR: WHI-07: A Novel Dual-Function Microbicide$378,654
R44 · FY2005 · HD
Stampidine: A Novel Broad-Spectrum Anti-HIV Microbicide$100,000
R43 · FY2005 · AI
Phase II SBIR: WHI-07: A Novel Dual-Function Microbicide$371,348
R44 · FY2004 · HD
PHI-443: Novel Non-Spermicidal Anti-HIV Microbicide$100,001
R43 · FY2003 · HD
Vanadocenes as a New Class of Spermicidal Drugs$100,000
R43 · FY2003 · HD
PHI 346: A Novel Dual-Function Microbicide$100,000
R43 · FY2003 · AI
METVAN: A Novel Anticancer Agent$100,000
R43 · FY2003 · CA
FLP-102: Rationally Engineered Antiviral Protein$100,000
R43 · FY2003 · GM
WHI-07: A Novel Dual-Function Microbicide$100,000
R43 · FY2002 · HD
NOVEL CONTRACEPTIVES WITH ANTI-HIV ACTIVITY$253,048
R01 · FY2001 · HD
NOVEL CONTRACEPTIVES WITH ANTI-HIV ACTIVITY$245,678
R01 · FY2000 · HD